Get breaking news alerts via email

Click here to manage your alerts
Initial public offerings scheduled to debut next week
First Published Jun 13 2014 11:28 am • Last Updated Jun 13 2014 11:28 am

New York • The following is a list of initial public offerings planned for the coming week. Sources include Renaissance Capital, Greenwich, CT (www.renaissancecapital.com) and SEC filings.

Week of June 16:

Join the Discussion
Post a Comment

Ardelyx Inc. - Fremont, Calif., 3.6 million shares, priced $13 to $15, managed by Citigroup and Leerink Partners. Proposed Nasdaq symbol ARDX. Business: Biotech developing small molecule treatments for kidney and gastrointestinal diseases.

Century Communities Inc. - Greenwood Village, Colo., 4.5 million shares, priced $23 to $26, managed by FBR Capital Markets, J.P. Morgan, and Deutsche Bank. Proposed NYSE symbol CCS. Business: Single-family homebuilder primarily in Colorado, as well as Texas and Nevada.

Eclipse Resources Corp. - State College, Pa., 30.3 million shares, priced $27 to $30, managed by Citigroup, Goldman Sachs, and Morgan Stanley. Proposed NYSE symbol ECR. Business: Oil and natural gas E&P operating in the Appalachian Basin.

Foresight Energy LP - St. Louis, Mo., 17.5 million shares, priced $19 to $21, managed by Barclays, Citigroup, and Morgan Stanley. Proposed NYSE symbol FELP. Business: Spinoff of Foresight Reserves with 3 billion tons of coal reserves in the Illinois basin.

Kite Pharma Inc. - Santa Monica, Calif., 6 million shares, priced $12 to $14, managed by Jefferies, Credit Suisse, and Cowen & Co. Proposed Nasdaq symbol KITE. Business: Clinical stage biotech developing an immunotherapy cancer treatment.

Markit Ltd. - London, U.K., 45.7 million shares, priced 23 to $25, managed by BofA Merrill Lynch, Barclays, and Citigroup. Proposed Nasdaq symbol MRKT. Business: Largest provider of bond information and derivatives trade processing.

Microlin Bio Inc. - New York, 2.7 million shares, priced $10 to $12, managed by Brean Capital and Summer Street Research. Proposed Nasdaq symbol MCLB. Business: Development stage diagnostic and therapeutics company focusing on microRNA and its role in oncology. Issue was previously postponed.

Parnell Pharmaceuticals Holdings Ltd. - Alexandria, Australia, 3.6 million ordinary shares, priced $17 to $19, managed by Jefferies and Piper Jaffray. Proposed Nasdaq symbol PARN. Business: Provides drugs and health software for production and companion animals.

story continues below
story continues below

Syndax Pharmaceuticals Inc. - Waltham, Mass., 4.3 million shares, priced $13 to $15, managed by Deutsche Bank and Jefferies. Proposed Nasdaq symbol SNDX. Business: Late-stage biotech developing a novel therapy for treatment-resistant breast cancer.

Viper Energy Partners LP - Midland, Texas, 5 million common units, priced $19 to $21, managed by Barclays, Credit Suisse, and Wells Fargo. Proposed Nasdaq symbol VNOM. Business: Oil and gas E&P in the Permian Basin spun out of Diamondback Energy.

Zafgen Inc. - Cambridge, Mass., 5 million shares, priced $14 to $16, managed by Leerink Partners and Cowen & Co. Proposed Nasdaq symbol ZFGN. Business: Clinical-stage biotech developing treatments for severe obesity and hunger-related disorders.

ZS Pharma Inc. - Coppell, Texas, 5 million shares, priced $15 to $17, managed by J.P. Morgan and Credit Suisse. Proposed Nasdaq symbol ZSPH. Business: Late-stage biotech developing a treatment for excess potassium (hyperkalemia).

Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Top Reader Comments Read All Comments Post a Comment
Click here to read all comments   Click here to post a comment

About Reader Comments

Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
Staying Connected
Contests and Promotions
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.